Sage Group PLC (The)
28 August 2026
28 August 2026
The Sage Group plc
Publication of a Supplementary Base Prospectus
The Sage Group plc (FTSE: SGE) ("Sage"), a leader in accounting, financial, HR and payroll technology for small and mid-sized businesses, announces that the following Supplement to the Base Prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Supplement dated 28 August 2026 ("Supplement") to the Base Prospectus for Sage’s £3,000,000,000 Euro Medium Term Note Programme dated 5 February 2026 ("Base Prospectus") unconditionally and irrevocably guaranteed by Sage Treasury Company Limited.
To view the full document, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/6613S_1-2026-8-28.pdf.
A copy of the Supplement has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
Sage +44 (0) 7341 479956
Alexander Hall, Group Financial Controller
James Thomas, Treasury
James Sandford, Investor Relations
Becky Potgieter, Corporate PR
FGS Global +44 (0) 20 7251 3801
Conor McClafferty
Sophia Johnston
About Sage
Sage exists to knock down barriers so everyone can thrive, starting with the millions of small and mid-sized businesses (SMBs) served by us, our partners and accountants. Customers trust our finance, HR and payroll software to make work and money flow. By digitalising business processes and relationships with customers, suppliers, employees, banks and governments, our AI-powered platform connects SMBs, removing friction and delivering insights. Knocking down barriers also means we use our time, technology and experience to tackle digital inequality, economic inequality and the climate crisis.
The Sage Group plc's LEI is 2138005RN5XYLTF8G138.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Base Prospectus, as supplemented by the Supplement, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus, as supplemented) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus, as supplemented, is not addressed. Prior to relying on the information contained in the Base Prospectus, as supplemented, you must ascertain from the Base Prospectus, as supplemented, whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of the Notes described in the Base Prospectus, as supplemented, for sale in the United States.This is not for distribution in the United States.The Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to U.S. tax law requirements.Subject to certain exceptions, Notes may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons, as such terms are defined in Regulation S under the Securities Act.There will be no public offering of the Notes in the United States.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.